Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Andrus

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Scandinavian Journal of Immunology|May 1, 1981
Inhibition of T-cell activity by cyclosporin AL Andrus, K J Lafferty
The Australian Journal of Experimental Biology and Medical Science|December 1, 1980
Cellular requirements for production and release of the lymphocyte costimulatorL Andrus, K J Lafferty
The Australian Journal of Experimental Biology and Medical Science|August 1, 1981
Interleukin 2 production by alloantigen (H-2) activated T cellsL Andrus, K J Lafferty
Biotechniques|March 1, 1992
PCR: how to kill unwanted DNAA M Prince, L Andrus
The Journal of Experimental Medicine|September 1, 1984
Antibodies to interleukin 2. Effects on immune responses in vitro and in vivoA Granelli-Piperno, L Andrus, E Reich
The Journal of Experimental Medicine|February 1, 1984
Cytotoxic T cells both produce and respond to interleukin 2L Andrus, A Granelli-Piperno, E Reich
Clinical and Experimental Immunology|December 1, 1982
Lethal effect of the intravenous injection of H-2 alloantigen activated T cellsL Andrus, K Atkinson, K J Lafferty
Scandinavian Journal of Immunology|January 1, 1981
Interleukin 2 production by both Ly2+ and Ly2- T-cell subsetsL Andrus, S J Prowse, K J Lafferty
The Journal of Experimental Medicine|April 1, 1986
Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin AA Granelli-Piperno, L Andrus, R M Steinman
Diabetes|January 1, 1980
Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipientsK M Bowen, L Andrus, K J Lafferty
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Immunology|May 1, 1981
Inhibition of T-cell activity by cyclosporin AL Andrus, K J Lafferty
The Australian Journal of Experimental Biology and Medical Science|December 1, 1980
Cellular requirements for production and release of the lymphocyte costimulatorL Andrus, K J Lafferty
The Australian Journal of Experimental Biology and Medical Science|August 1, 1981
Interleukin 2 production by alloantigen (H-2) activated T cellsL Andrus, K J Lafferty
Biotechniques|March 1, 1992
PCR: how to kill unwanted DNAA M Prince, L Andrus
The Journal of Experimental Medicine|September 1, 1984
Antibodies to interleukin 2. Effects on immune responses in vitro and in vivoA Granelli-Piperno, L Andrus, E Reich
The Journal of Experimental Medicine|February 1, 1984
Cytotoxic T cells both produce and respond to interleukin 2L Andrus, A Granelli-Piperno, E Reich
Clinical and Experimental Immunology|December 1, 1982
Lethal effect of the intravenous injection of H-2 alloantigen activated T cellsL Andrus, K Atkinson, K J Lafferty
Scandinavian Journal of Immunology|January 1, 1981
Interleukin 2 production by both Ly2+ and Ly2- T-cell subsetsL Andrus, S J Prowse, K J Lafferty
The Journal of Experimental Medicine|April 1, 1986
Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin AA Granelli-Piperno, L Andrus, R M Steinman
Diabetes|January 1, 1980
Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipientsK M Bowen, L Andrus, K J Lafferty
Pageof 3